Does DENOSUMAB Cause Metastatic malignant melanoma? 16 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 16 reports of Metastatic malignant melanoma have been filed in association with DENOSUMAB (Bilprevda). This represents 0.0% of all adverse event reports for DENOSUMAB.
16
Reports of Metastatic malignant melanoma with DENOSUMAB
0.0%
of all DENOSUMAB reports
4
Deaths
4
Hospitalizations
How Dangerous Is Metastatic malignant melanoma From DENOSUMAB?
Of the 16 reports, 4 (25.0%) resulted in death, 4 (25.0%) required hospitalization, and 1 (6.3%) were considered life-threatening.
Is Metastatic malignant melanoma Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for DENOSUMAB. However, 16 reports have been filed with the FAERS database.
What Other Side Effects Does DENOSUMAB Cause?
Off label use (34,612)
Death (16,545)
Osteonecrosis of jaw (8,438)
Arthralgia (5,890)
Pain in extremity (4,541)
Back pain (4,465)
Pain (4,102)
Product storage error (3,621)
Fall (3,322)
Fatigue (3,009)
What Other Drugs Cause Metastatic malignant melanoma?
DABRAFENIB (449)
TRAMETINIB DIMETHYL SULFOXIDE (267)
TRAMETINIB (173)
SILDENAFIL (116)
TALIMOGENE LAHERPAREPVEC (109)
NIVOLUMAB (87)
PREDNISONE (77)
PEMBROLIZUMAB (74)
TADALAFIL (71)
IPILIMUMAB (69)
Which DENOSUMAB Alternatives Have Lower Metastatic malignant melanoma Risk?
DENOSUMAB vs DEOXYCHOLIC ACID
DENOSUMAB vs DEPAKINE CHRONO
DENOSUMAB vs DEPAKOTE
DENOSUMAB vs DEPO-PROVERA
DENOSUMAB vs DERMATOPHAGOIDES FARINAE